chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PATIENT COMPLAINED OF HEADACHE AND NASAL PRESSURE WITHIN 30 MINUTES OF RECEIVING VACCINE. SYMPTOMS INCREASED WHEN DORSO FLEX NECK.
Reported to store on 10/05/17 at approx 1pm. Received a dose of FLUZONE HD previous day in L delt. Pt presented today with an area of bruising at and just below the injection site. Referred her to her primary care Dr. I initiated a call to Dr.'s office at approximately 2pm. Reached out to the patient on 10/6/17 at approximately 10am and left message. At approximately 10:30 am pt called and spoke to my technician. Patient reported that the area on her arm was improving and she was feeling much better.
Fever (sweating), temperature unknown, on night of 9/25 and during day of 9/26. Raised, swollen, red, hot at site of injection.
Acute right-sided thoracic back pain. ED visit to hospital admission. This visit was within 6 weeks of receiving the COVId vaccine.
As of 4/21/21 still getting daily headaches that started with my second Moderna dose.  Contacted PCP.  They stated 3-4 weeks is normal and would now like me to see neurolorgy.
headache, body and muscle aches, 100 degree fever, dizziness, fatigue
Subsequent to receiving one dose of varicella virus vaccine live the pt was found to have a negative varicella antibody. Consequently the pt received a second dose of varicella virus vaccine. No further testing reported.
Low grade fever; Chills; Sweats; Headache; This is a spontaneous report from a contactable consumer. A 16-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the left arm on 04May2021 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The reporter was made aware of the events following the second dose. On 04May2021, the patient experienced low grade fever, chills, sweats and headache. It resolved within a day. There were no events noted after receiving the first dose. The reporter was informed of this event on 05May2021 at approximately 21:00. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events low grade fever, chills, sweats and headache was resolved within a day on 05May2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Pt reports L arm pain and numbness, extending down to 4th and 5th finger, weakness in hand earlier today upon waking. No current numbness/weakness, resolved this AM. Now having mainly deltoid pain, especially with raising arm
This spontaneous report as received from a pharmacist refers to a patient of unknown demographics. No current condition was reported. No historical medication was reported. On an unknown date the patient was vaccinated with PNEUMOVAX 23 (route- subcutaneous, dose strength was not reported). No concomitant medication was reported. On an unknown date the patient experienced very swollen injection site which was painful and red. The outcome of very swollen injection site which was painful and red was reported as not resolved. Causality was unknown. Patient sought medical attention was reported as yes, contacted pharmacy. Treatment provided for adverse event and laboratory diagnostics studies performed was reported as none. No PQC was involved. No further information reported. No further information provided. Additional information is not expected.
This spontaneous report as received from a Registered nurse, refers to an approximately 14 year old, female patient. On 05-SEP-2013, the patient was vaccinated with the first dose of GARDASIL, 0.5 ml, (lot J002641, expiration date 17-MAY-2013), intramuscular. Co-suspect therapies were not reported. Concomitant therapies included BOOSTRIX and multivitamins (unspecified). On 05-SEP-2013, registered nurse reported that the patient developed hives after receiving the first dose of GARDASIL. The reporter stated that the hives were all over the body, even between her hair lines. Patient saw a nurse practitioner for the event. On 07-SEP-2013, two days after vaccination, the patient recovered from the event. At the time of the report, the causality for the event was unknown. Additional information has been requested.
Information has been received from an office manager concerning a female who was vaccinated with GARDASIL (lot number: 662520/0120Y, dose, route not reported) for immunization. The patient finished HPV vaccination (name, manufacturer unspecified) but came down with positive result for HPV infection. It was unspecified if the patient sought medical attention. Additional information has been requested.
Sore arm at the injection site after first dose; Chills after first dose; Felt little tired after first dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm at the injection site after first dose), CHILLS (Chills after first dose) and FATIGUE (Felt little tired after first dose) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION SITE PAIN (Sore arm at the injection site after first dose), CHILLS (Chills after first dose) and FATIGUE (Felt little tired after first dose). On 24-Mar-2021, VACCINATION SITE PAIN (Sore arm at the injection site after first dose), CHILLS (Chills after first dose) and FATIGUE (Felt little tired after first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were mentioned. No treatment drugs were reported.   This case was linked to MOD-2021-114616 (Patient Link).
24-48 hrs of localized edema, soreness which completely resolved. Then, 6 days after injection I awoke with tremendous localized  itching  and edema and erythema.  It lasted 24 hrs approx.
Headache and chills for several hours, strong heartbeat, site of injection hot and painful.
Aches; HEADACHE; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aches) and HEADACHE (HEADACHE) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19.  On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN (Aches) and HEADACHE (HEADACHE). At the time of the report, PAIN (Aches) and HEADACHE (HEADACHE) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were reported.  Treatment details was not provided.
I was fine the shot didn't give me any issues necessarily. My pustular psoriasis retrigged after being in remission for 40 years and now I also have a new psoriasis called plaque psoriasis. I went to the dermatologist and was prescribed triamcinolone acetonide ointment uxp0.1%.
Approx 1 hr p/receiving vax pt woke up w/high shrill cry lasting a few minutes; Continued in this pattern (sleeping, awaken w/shrill cry) every 45 min for about 8 hrs; back to nl in 18 hrs; t101;
This case was reported by a consumer via call center representative and described the occurrence of gout in a adult male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, 4 days after receiving SHINGRIX, the patient experienced gout. On an unknown date, the outcome of the gout was unknown. It was unknown if the reporter considered the gout to be related to SHINGRIX. Additional case details were reported as follows: The age at vaccination was not reported. The patient declined to give any contact information. The patient previously reported this event via VAERS. The reporter did not consent to follow up.
Was vaccinated with varicella vaccine on 06/26/2002. Came into clinic on 03/27/2003 with breakthrough case of chicken pox.
Vaccine 1: 02.26.21 Side effect on 02/04.21-vertigo, vomiting, shortness of breath, jaw tingling, diarrhea.  02.10.21 - vertigo, jaw tingling, shortness of breath, tinnitus, nausea, headache  02.24.21 - vertigo,  nausea, tinnitus, headache.  Bouts of dizziness, headaches & tinnitus continue.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 52-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 20Oct2022 as dose 5 (booster), single (Lot number: GH9693) at the age of 51 years, in right arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Multiple sclerosis" (unspecified if ongoing); "Known allergies: Sulfa" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: The patient was given Paxlovid from 25Oct2023 to 29Oct2023.   No follow-up attempts are possible. No further information is expected.
Dr. is a primary care physician who comes to our facility. He was vaccinated on 1/7/21 and 1/28/21 with the Pfizer Covid-19 vaccine.  He tested positive on 4/4/21.
received immunizations on 5/14/2004. On 5/17/2004 child awakened covered in hives according to mother.  On 5/19/2004 mother called this staff who referred her to her private physician.  Treated with benadryl.
pt states by noon after taking 2nd dose she had developed itching, chills, headache, body pain, and head was foggy.  Pt had very odd body aches and pains, itching, and headaches that would come and go for weeks.  These symptoms lasted at least 22 days before subsiding.  Pt contacted her PCP and was told to take Claritin.  Pt also had an annual appt w/ PCP where she did blood work but pt has not received any results.  Pt no longer has these symptoms.
Initial unsolicited report received from a consumer on 18-MAY-2017. This case involves a patient (gender and age was not reported) who was vaccinated with a dose of YELLOW FEVER VACCINE (batch number, expiry date, dose, dose in series, route and site of administration were not reported) on an unknown date. The patient's medical history and concomitant medications were not reported. On 05 May 2017, following the vaccination, the patient fainted and lost consciousness briefly. The patient's laboratory data and corrective treatment was not reported. On an unknown date, the patient recovered from the events. Upon internal review, the case was considered as serious due to important medical event: losing consciousness briefly. List of documents held by sender: none.; Sender's Comments: The patient fainted and lost consciousness briefly after vaccination with YELLOW FEVER VACCINE (MFR UNK). Time to onset was not reported. Loss of consciousness following a vaccination can result due to several factors nervousness and fear of needle resulting in drop of blood pressure being few of them. No information regarding patient's condition at the time of vaccination or occurrance of similar events at the time of vaccinations in past has not been provided. Based on the available information the role of the vaccine can not be assessed.
Large red swollen area that feels warm and itchy.  About 2 inches in diameter.
Within 12 hours, I had a normal reaction for 2-6 days with fever, chills, and headache. Then maybe a couple of weeks later my heart was racing and that continued throughout the summer, and I went to the Doctor because it was bothering me, so they did a heart monitor, and I was diagnosed with sinus tachycardia, and they started me on medication for it. The medication is helping, but I still feel it, but if I wasn't on the medication, I would really be able to feel it.
fine raised rash across chest, back, abd.  slightly itchy. worsening over several days when seen in  Office visit 11/8/21.  continued to worsen through 11/10/21 when last wrote me.  it appeared similar to a viral exanthem.
45 minutes after receiving MENACTRA pt developed chest pain & shortness of breath.  She was seen in ED where wheezing was heard.  She was treated with 1 dose of BENADRYL, prednisone & nebulizer x1.
Less than 5 minutes after the vaccine was administered patient developed chills and began shivering uncontrollably, teeth chattering, stomach felt uneasy and she became nauseated, sore throat and tightness.
Initial unsolicited report received from a pharmacist on 2 September 2015. This case involves a 17-year-old female patient who had received a dose (route of administration unknown) of MENACTRA (batch number U5178AA, expiry date: 17 January 2017) in right deltoid on 1 September 2015. The patient's pre-existing physician diagnosed allergies, birth defects, medical conditions was reported as no known allergies (NKA) none and illness at time of vaccination was none. Concomitant medications were reported as none. On 2 September 2015, one day after the vaccination the patient experienced headache and neck pain and also felt generally ill. The patient required ER visit. Laboratory investigations were reported as none. Corrective treatments were not reported. The event outcome was unknown. Documents held by sender: none. Follow-up information received from a pharmacist on 29 September 2015. It was reported that patient did not require ER doctor visit. Patient had followed up with school nurse. Stated and country where vaccine administered was reported. Follow-up information received from a pharmacist on 2 November 2015. No new information reported.
someone received a third dose is that harmful; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EXTRA DOSE ADMINISTERED (someone received a third dose is that harmful) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXTRA DOSE ADMINISTERED (someone received a third dose is that harmful). At the time of the report, EXTRA DOSE ADMINISTERED (someone received a third dose is that harmful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Relevant concomitant medications was reported.  Treatment information was not provided.
Flush, hot, weak, History of Diabetic Mellitus. Pt. Didn't eat before coming to site. EMT gave drinks and snacks.  Pt. verbalized feeling anxious. d/t information on TV. R/T adverse reactions. D/C'd at 13:15 to home. Seen by EMT:  Recorded by :
Patient woke up intensely nauseous around 11:30 PM, walked to the bathroom, felt sudden full-body stiffness and then passed out. Patient woke up on the floor about 5 minutes later, where she remained for 10 more minutes until the muscle stiffness subsided enough for her to return to bed. Nausea subsided enough after an hour for her to return to sleep.
After 3 weeks of not being able to move my arm and constantly feeling like I was being stabbed by a knife in my anterior deltoid, an Orthopedic Surgeon confirmed that my nerve was hit when the injection was given. It will take 8-10 weeks for my nerve to regenerate, I hope.
itchy; swelling of lips; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy) and LIP SWELLING (swelling of lips) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itchy) and LIP SWELLING (swelling of lips). At the time of the report, PRURITUS (itchy) and LIP SWELLING (swelling of lips) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported. Treatment for the pruritus includes cream.
Information has been received from a physician concerning a male with no pertinent medical history who was vaccinated SC with a dose of Zostavax. Subsequently three days after vaccination the patient experienced renal failure and high calcium and was hospitalized for five days. No additional information was provided. There was no product quality complaint involved. Additional information has been requested.
Increased Swelling Injection Site ( a little larger than palm of her hand); Swollen Injection Site (Size of palm of hand); Red Injection Site (Size of palm of hand); This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (Swollen Injection Site (Size of palm of hand)), INJECTION SITE ERYTHEMA (Red Injection Site (Size of palm of hand)) and INJECTION SITE SWELLING (Increased Swelling Injection Site ( a little larger than palm of her hand)) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, the patient experienced INJECTION SITE SWELLING (Swollen Injection Site (Size of palm of hand)) and INJECTION SITE ERYTHEMA (Red Injection Site (Size of palm of hand)). On 27-May-2021, the patient experienced INJECTION SITE SWELLING (Increased Swelling Injection Site ( a little larger than palm of her hand)). At the time of the report, INJECTION SITE SWELLING (Swollen Injection Site (Size of palm of hand)), INJECTION SITE ERYTHEMA (Red Injection Site (Size of palm of hand)) and INJECTION SITE SWELLING (Increased Swelling Injection Site ( a little larger than palm of her hand)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was unknown
My tongue feels funny. Food doesn't taste as it used to and I have no appetite. I have lost 22 lbs. I am down to 100lbs.
Got COVID; Got really sick (tested positive for COVID) for 12 days until she got negative results again; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Got COVID) and ILLNESS (Got really sick (tested positive for COVID) for 12 days until she got negative results again) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Exposed to COVID on 09 Aug 2021) on 09-Aug-2021.    On 11-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced COVID-19 (Got COVID) and ILLNESS (Got really sick (tested positive for COVID) for 12 days until she got negative results again). In August 2021, COVID-19 (Got COVID) and ILLNESS (Got really sick (tested positive for COVID) for 12 days until she got negative results again) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2021, Antibody test: high (High) Ab levels were already high. In August 2021, SARS-CoV-2 test: positive (Positive) Tested positive for COVID and negative (Negative) She got negative results again.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported.  Treatment information was not provided.   Reporter did not allow further contact
The pain in my sacral area and buttocks starts as a dull pain that progresses as the day goes on (climbing stairs is real hard). The top of my feet are sore to the touch and toes hurt real bad making walking difficult. The balls of my feet hurt real bad and I get sharp pains in my toes and fingers. The pain only last for a few seconds but is very severe. The tendons in my fingers and forearm are very sore especially when I try to rest. The tendons in my fingers hurt really bad when I extend them and sometimes they go numb. My forearm and shoulder muscles feel like they are sunburned on the inside. They burn and have a dull ache; at times the pain will bring tears. Between my shoulder blades also burns and is stiff. When standing for about 1 hour, my hip joints start hurting. The joints in my knees feel as if they are swollen, it is hard going down stairs or getting up. I have to use something to help pull myself up. My knees also have a tingling feeling. I also get very fatigued all the time and I usually lie down for a nap everyday. I have problems concentrating in reading or working on a project at home. There are days when I hurt so bad that I just go lie on the bed and wonder when will I ever get better. I have difficulty in falling asleep every night even when I take sleeping pills (which is every night). I never go any day without taking something for pain but I always feel that there is some hope. Whenever I drive or sit for about 10 minutes, I can hardly get up. Sometimes it is so painful that I get tears in my eyes. The last day I worked was 7/15/99.